Related Experiment Video
Updated: May 14, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
[What's new in HIV/AIDS: Some selected topics]
1Service des maladies infectieuses HUG, 1211 Genève 14. diem-lan.vu@hcuge.ch
Revue Medicale Suisse
|February 16, 2013
Summary
Early antiretroviral therapy and pre-exposure prophylaxis are key HIV/AIDS management strategies. Novel treatments show promise for future HIV prevention and care.
Area of Science:
- Infectious Diseases
- Virology
- Public Health
Context:
- 2012 saw significant advancements in HIV/AIDS management strategies.
- Emerging therapies and evolving treatment guidelines marked the year.
- Increased focus on HIV prevention methods, including pre-exposure prophylaxis.
Purpose:
- To discuss the critical timing of initiating antiretroviral therapy (ART).
- To review the impact of pre-exposure prophylaxis (PrEP) on HIV transmission prevention.
- To explore novel therapeutic molecules for future HIV treatment strategies.
Summary:
- The optimal timing for initiating antiretroviral therapy (ART) is increasingly recognized as earlier.
- The U.S. validation of pre-exposure prophylaxis (PrEP) has revitalized focus on HIV transmission prevention.
- Emerging drug candidates with improved mechanisms, half-life, or reduced dosage offer new treatment avenues.
Impact:
- Shifts in ART initiation timing can improve patient outcomes.
- Wider adoption of PrEP can significantly reduce new HIV infections.
- Novel therapeutic agents may lead to more effective and manageable HIV treatment regimens.
More Related Videos
Related Concept Videos
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.